Perspective Therapeutics, Inc. (CATX) vs InfuSystems Holdings, Inc. (INFU)
Perspective Therapeutics, Inc. and InfuSystems Holdings, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $285.4M against $252.8M — 1.1× the size. Perspective Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 30.3×. InfuSystems Holdings, Inc. grew revenue faster over the last twelve months: 2.47% against −66.9%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −28,468.0%) and the higher return on invested capital (10.6% vs −88.4%). Across the 19 metrics below, InfuSystems Holdings, Inc. leads on 14 and Perspective Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CATX | INFU | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 57.45% | 56.01% |
| Operating margin | (30,619.07%) | 9.26% | (15.03%) |
| Net margin | (28,467.97%) | 5.96% | (20.40%) |
| Free cash flow margin | (29,630.07%) | 10.56% | (7.24%) |
| Return on equity | (39.50%) | 15.03% | (15.32%) |
| Return on assets | (33.14%) | 8.61% | (19.72%) |
| Return on invested capital | (88.41%) | 10.55% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack